scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.METABOL.2006.10.010 |
P698 | PubMed publication ID | 17292717 |
P2093 | author name string | Dominique Bonnefont-Rousselot | |
Claudine Cosson | |||
Jean-Louis Beaudeux | |||
Alain Legrand | |||
Jacqueline Peynet | |||
Nadjat Ouslimani | |||
Meriem Mahrouf | |||
P2860 | cites work | Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species | Q44987425 |
P433 | issue | 3 | |
P921 | main subject | metformin | Q19484 |
P304 | page(s) | 308-313 | |
P577 | publication date | 2007-03-01 | |
P1433 | published in | Metabolism | Q15764354 |
P1476 | title | Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 | |
P478 | volume | 56 |
Q64258986 | A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function |
Q51747235 | AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease. |
Q26774333 | Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS? |
Q33611742 | Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice |
Q42014552 | Beneficial Effects of Teucrium polium and Metformin on Diabetes-Induced Memory Impairments and Brain Tissue Oxidative Damage in Rats. |
Q38831558 | Cellular mechanisms and consequences of glycation in atherosclerosis and obesity |
Q42363364 | Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs |
Q46926316 | Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects |
Q34987953 | Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study |
Q34079451 | LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. |
Q54384581 | Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein. |
Q34919719 | Metformin restores endothelial function in aorta of diabetic rats |
Q35475499 | The discovery of LOX-1, its ligands and clinical significance |
Search more.